Explore more
News
The stock's fall snapped a two-day winning streak.
2don MSN
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater ...
StockStory.org on MSN11h
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To KnowA number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions ...
We came across a bullish thesis on Gilead Sciences, Inc. on Dividend Talks’s Substack. In this article, we will summarize the ...
Gilead Sciences Inc. closed 5.60% below its 52-week high of $119.96, which the company achieved on March 10th.
Zacks Investment Research on MSN3d
Gilead Sciences Rallies 27.2% in Six Months: Buy or Sell the Stock?Shares of Gilead Sciences, Inc. GILD have gained 27.2% in the past six months against the industry’s decline of 2.2%. The ...
(Reuters) -Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized ...
Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...
Gilead Sciences is pushing full speed ahead with its strategy to ensure global access to its long-acting HIV pre-exposure ...
See the latest Gilead Sciences GILD stock price (NASDAQ: GILD), related news, valuation, dividends and more to help you make your investing decisions.
Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback